×
The Standard e-Paper
Home To Bold Columnists
The Standard Group Plc is a
multi-media organization with investments in media platforms spanning newspaper
print operations, television, radio broadcasting, digital and online services. The
Standard Group is recognized as a leading multi-media house in Kenya with a key
influence in matters of national and international interest.
A cervical cancer treatment originated in Kenya is set for a decisive research phase in Australia and New Zealand. The treatment, a combination of two HIV drugs, will from January be tested on 36 volunteers with early cervical cancer.
The one-year clinical trials will be testing whether the viginal ointment is able to treat or cure cervical cancer in the early stages. Sponsored by a New Zealand pharmaceutical company, the trials will also assess the effectiveness, safety and tolerability of the treatment.
Subscribe to our newsletter and stay updated on the latest developments and special offers!
join